Literature DB >> 2108951

Methotrexate cytotoxicity as related to irreversible S phase arrest in mouse L1210 leukemia cells.

M Tsurusawa1, M Niwa, N Katano, T Fujimoto.   

Abstract

The association between cytotoxicity and cell cycle perturbation caused by methotrexate (MTX) was investigated in mouse L1210 leukemia cells by flow cytometric bromodeoxyuridine/DNA assay. In the range of concentrations of MTX from 10(-7) M to 10-6) M, in vitro exposure to the drug for 6 h caused a dose-dependent suppression of clonal growth of the tumor cells and S phase arrest in the cycle progression, resulting in an accumulation of cells in early S phase, in which they showed no definite increase of DNA content above G1 levels. The surviving fraction of the clonogenic cells corresponded with the fraction of cells which recovered from the S phase arrest in MTX-free medium. In mice bearing L1210 ascites tumors, a bolus injection of MTX caused the S phase arrest of the tumor cells as shown in suspension cultures, and cytokinetic recovery was observed in parallel with the regrowth of the tumor. These results showed that irreversible S phase arrest is a critical cytokinetic event associated with the cytotoxicity of MTX.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108951      PMCID: PMC5917961          DOI: 10.1111/j.1349-7006.1990.tb02511.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

Review 1.  Polyglutamation of methotrexate. Is methotrexate a prodrug?

Authors:  B A Chabner; C J Allegra; G A Curt; N J Clendeninn; J Baram; S Koizumi; J C Drake; J Jolivet
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

2.  Flow cytometric analysis of marrow cell kinetics in children treated with high-dose MTX and CF rescue.

Authors:  M Tsurusawa; K Sasaki; H Matsuoka; Y Yamamoto; N Katano; T Fujimoto
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Comparison of the effects of several inhibitors of the synthesis of nucleic acids upon the viability and progression through the cell cycle of cultured H. Ep. no. 2 cells.

Authors:  G P Wheeler; B J Bowdon; D J Adamson; M H Vail
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

4.  Perturbation of generation cycle of human leukemic myeloblasts in vivo by methotrexate.

Authors:  P Ernst; S A Killmann
Journal:  Blood       Date:  1971-12       Impact factor: 22.113

5.  Marrow cell kinetics in patients treated with methotrexate and citrovorum factor.

Authors:  W R Vogler; Z H Israili; A G Soliman; S Moffitt; B Barlogie
Journal:  Cancer       Date:  1981-01-15       Impact factor: 6.860

6.  Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells.

Authors:  J Jolivet; R L Schilsky; B D Bailey; J C Drake; B A Chabner
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  Cytokinetic and cytotoxic effects of antimetabolites on 9L rat brain tumor cells in vitro.

Authors:  M Weizsaecker; T Hoshino; D F Deen; S Kobayashi
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

8.  Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineages.

Authors:  J P Bökkerink; R A De Abreu; M A Bakker; T W Hulscher; J M van Baal; E D Schretlen; C H De Bruijn
Journal:  Biochem Pharmacol       Date:  1988-06-15       Impact factor: 5.858

9.  S phase-specific synthesis of dihydrofolate reductase in Chinese hamster ovary cells.

Authors:  B D Mariani; D L Slate; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.

Authors:  M Tsurusawa; M Niwa; N Katano; T Fujimoto
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

View more
  7 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

2.  A flow cytometric bromodeoxyuridine/DNA analysis for cytokinetics of the pancreatic cancer cell line Capan-2 after irradiation.

Authors:  B Nakata; Y S Chung; M Sowa
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Flow cytometric bromodeoxyuridine/DNA analysis of hyperthermia and/or adriamycin for human pancreatic adenocarcinoma cell line Capan-2.

Authors:  B Nakata; Y S Chung; H Yokomatsu; T Sawada; T Kubo; Y Kondo; K Satake; M Sowa
Journal:  Jpn J Cancer Res       Date:  1992-05

4.  Anticancer Effect of Deuterium Depleted Water - Redox Disbalance Leads to Oxidative Stress.

Authors:  Xuepei Zhang; Massimiliano Gaetani; Alexey Chernobrovkin; Roman A Zubarev
Journal:  Mol Cell Proteomics       Date:  2019-09-13       Impact factor: 5.911

5.  Biocompatibility and cytotoxicity in vitro of surface-functionalized drug-loaded spinel ferrite nanoparticles.

Authors:  Sadaf Mushtaq; Khuram Shahzad; Tariq Saeed; Anwar Ul-Hamid; Bilal Haider Abbasi; Nafees Ahmad; Waqas Khalid; Muhammad Atif; Zulqurnain Ali; Rashda Abbasi
Journal:  Beilstein J Nanotechnol       Date:  2021-12-02       Impact factor: 3.649

Review 6.  Cancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate.

Authors:  Joshua A Hess; Mohamad K Khasawneh
Journal:  BBA Clin       Date:  2015-02-07

7.  Non-destructive, label free identification of cell cycle phase in cancer cells by multispectral microscopy of autofluorescence.

Authors:  Jared M Campbell; Abbas Habibalahi; Saabah Mahbub; Martin Gosnell; Ayad G Anwer; Sharon Paton; Stan Gronthos; Ewa Goldys
Journal:  BMC Cancer       Date:  2019-12-21       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.